Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I. J. Widding Hansen"'
Autor:
Erik Rødevand, A. Diamantopoulos, I. J. Widding Hansen, Glenn Haugeberg, Gunnstein Bakland, A. H. Pripp
Publikováno v:
Annals of the Rheumatic Diseases. 80:543.1-543
Background:Biosimilar drugs follow a tailored approval pathway that usually includes a Phase III comparative efficacy randomized controlled trial with a high internal but low external validity. Therefore, observational studies with high external vali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5753c6a8234499e74448cc7383e457fd
https://doi.org/10.1136/annrheumdis-2021-eular.1604
https://doi.org/10.1136/annrheumdis-2021-eular.1604
Autor:
D. van der Heijde, Hallvard Fremstad, Siri Lillegraven, Daniel H. Solomon, Tor Magne Madland, Christian Høili, I. J. Widding Hansen, C. Spada, Nina Paulshus Sundlisæter, E. Moholt, Espen A Haavardsholm, Joseph O. Sexton, Inge C. Olsen, Maud-Kristine Aga Ljosa, Hilde Haukeland, Anna-Birgitte Aga, T. Uhlig, Åse Stavland Lexberg, Inger Marie Jensen Hansen, Gunnstein Bakland, T.K. Kvien
Publikováno v:
Annals of the Rheumatic Diseases. 79:1012.2-1013
Background:Sustained remission is the goal of rheumatoid arthritis (RA) care, and more patients reach and maintain this state on conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) with treat-to-target strategies. The knowledge a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c611f0ff48d7c4eae37ed5e6d08f60
https://doi.org/10.1136/annrheumdis-2020-eular.3090
https://doi.org/10.1136/annrheumdis-2020-eular.3090
Autor:
T. Sokka-Isler, Brigitte Michelsen, K. Paalanen, I. J. Widding Hansen, H. Berner Hammer, A. Kavanaugh, Glenn Haugeberg
Publikováno v:
Annals of the Rheumatic Diseases. 79:478.1-479
Background:Pain catastrophizing (the tendency to describe a pain experience in more exaggerated terms than the average person, to ruminate on it more, or to feel more helpless about it), has been associated with reduced likelihood of achieving remiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f34f5d133dbe66a98c32e94807e533e
https://doi.org/10.1136/annrheumdis-2020-eular.1635
https://doi.org/10.1136/annrheumdis-2020-eular.1635
Autor:
J. Asikainen, D.M. Soldal, I. J. Widding Hansen, T. Sokka-Isler, T. Rannio, Pekka Hannonen, Glenn Haugeberg
Publikováno v:
Annals of the Rheumatic Diseases. 73:462.3-462
Background Biologic drugs have improved outcomes of RA. However, many health care systems do not afford biologic drugs, and conventional DMARDs have to be used effectively including combinations. It was demonstrated in 2010 that good clinical outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5754ae29b9e82fb27dc1f50941bb837f
https://doi.org/10.1136/annrheumdis-2014-eular.2604
https://doi.org/10.1136/annrheumdis-2014-eular.2604
Publikováno v:
Annals of the Rheumatic Diseases. 72:A345.2-A345
Background Over the last decade, the use of outcome measures in daily clinical care has been endorsed by the rheumatology community and use of biologic treatment has become a part of modern rheumatology treating rheumatoid arthritis (RA), Psoriatic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3327d0504ffb66193674d6db09f81ca
https://doi.org/10.1136/annrheumdis-2013-eular.1064
https://doi.org/10.1136/annrheumdis-2013-eular.1064
Autor:
Tuulikki Sokka, D.M. Soldal, Pekka Hannonen, Arto Kokko, J. Asikainen, Glenn Haugeberg, I. J. Widding Hansen, T. Rannio
Publikováno v:
Annals of the Rheumatic Diseases. 71:341.2-341
Background According to a common consensus, remission/low disease activity is the treatment target in RA. Recommendations to reach the target are surprisingly different: ACR recommendations include a combination of conventional DMARDs for RA but EULA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::755dc77e78dbe1ef2224e984dccadde9
https://doi.org/10.1136/annrheumdis-2012-eular.2552
https://doi.org/10.1136/annrheumdis-2012-eular.2552